Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rossella Loria
Observed names:
LORIA, ROSSELLA,
Loria, Rossella,
R. Loria
Institution:
Instituto Nazionale Tumori Regina Elena
Observed institutions:
Istituti Fisioterapici Ospitalieri,
Istituti di Ricovero e Cura a Carattere Scientifico,
Instituto Nazionale Tumori Regina Elena
ORCID:
0000-0002-1305-2825
Observed ORCID:
0000-0002-1305-2825
OpenAlex ID:
A5025268176
Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
2019
·
Rossella Loria
, Claudia Giliberti
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
211
PDF
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells
2014
·
Rossella Loria
, Giulia Bon
, et al.
·
Oncotarget
·
86
PDF
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
2020
·
Giulia Bon
, Laura Pizzuti
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
81
PDF
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
2020
·
Dominga Racanelli
, Monica Brenca
, et al.
·
Frontiers in Oncology
·
59
PDF
Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells
2016
·
Donatella D’Eliseo
, Giuliana Di Rocco
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
54
PDF
Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer
2016
·
Lucia Cicchillitti
, Giacomo Corrado
, et al.
·
Oncotarget
·
53
PDF
Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers
2018
·
Giacomo Corrado
, Valentina Laquintana
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
51
PDF
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
2022
·
Rossella Loria
, Patrizia Vici
, et al.
·
Frontiers in Oncology
·
41
PDF
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
2018
·
Rossella Loria
, Valentina Laquintana
, et al.
·
Oncogene
·
33
PDF
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer
2019
·
Lorenza Bacci
, Aurora Aiello
, et al.
·
International Journal of Molecular Sciences
·
30
PDF
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
2022
·
Rossella Loria
, Valentina Laquintana
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
28
PDF
The prognostic significance of positive peritoneal cytology in endometrial cancer and its correlations with L1-CAM biomarker
2019
·
Enrico Vizza
, Emanuela Mancini
, et al.
·
Surgical Oncology
·
18
Three-dimensional preclinical models for Osteosarcoma: Advances and translational prospects
2025
·
Aurora Puce
, Virginia Ferraresi
, et al.
·
Biomedicine & Pharmacotherapy
·
13
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
2016
·
Giulia Bon
, Rossella Loria
, et al.
·
Oncotarget
·
9
PDF
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
2020
·
Dominga Racanelli
, Monica Brenca
, et al.
·
Frontiers in Oncology
·
8
PDF
The new world of RNA diagnostics and therapeutics
2023
·
Giovanni Blandino
, Roberto Dinami
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
7
PDF
HMGA1 is a new biomarker of liposarcoma progression
2017
·
R. Loria
, V. Laquintana
, et al.
·
Annals of Oncology
·
1
MicroRNAs and their role in heart transplantation insights into rejection mechanisms: A narrative review
2026
·
Rossella Loria
, Antonio Giuseppe Bianculli
, et al.
·
JHLT Open
PDF
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue
2022
·
Rossella Loria
, Patrizia Vici
, et al.
·
Frontiers in Oncology
PDF
Abstract 1887: Tumor-stroma interactions mediated by Semaphorin 6A as a determinant of drug resistance in BRAF-mut melanoma
2020
·
Rossella Loria
, Italia Falcone
, et al.
·
Cancer Research
Tumor-stroma interactions as a determinant of drug resistance in BRAF-mut melanoma
2017
·
I. Falcone
, R. Loria
, et al.
·
Annals of Oncology
Abstract 4721: Enhancement of doxorubicin cytotoxicity by histone deacetylase inhibition in human sarcoma cells
2016
·
Maria Grazia Tupone
, Daniela Trisciuoglio
, et al.
·
Cancer Research
Show more works
View as search
Works count:
33
Citation count:
784
H-index:
13
I10-index:
13
Year
Topic
Type